Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value

doi:10.5493/wjem.v15.i2.102761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (313)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-10) series.

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-10)

Sum=156

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=91

Publishing Process of This Article

Item

Count

Browse

Download

Sum=53

Jun 20, 2025 (publication date) through Apr 22, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Exp Med. Jun 20, 2025; 15(2): 102761
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.102761

Full Size Figure Download Figure

Figure 4 Presence of programmed cell death protein 1 ligand 1-positive fibroblastic stroma. A and B: Absence of programmed cell death protein 1 ligand 1-positive (PDCD1 LG1+) fibroblastic stroma; C and D: Presence of PDCD1 LG1+ fibroblastic stroma. Immunohistochemistry staining with antibodies against PDCD1 LG1. Magnification: A and C: 200 ×; B and D: 800 ×.

Citation: Zubareva EY, Senchukova MA, Saidler NV. Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value. World J Exp Med 2025; 15(2): 102761
URL: https://www.wjgnet.com/2220-315x/full/v15/i2/102761.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i2.102761